Enjoy complimentary customisation on priority with our Enterprise License!
The carrier screening market share is expected to increase to USD 2.36 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 17.66%.
The report extensively covers carrier screening market segmentation by the following:
The carrier screening market report offers information on several market vendors, including Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, DiaSorin SpA, F. Hoffmann La Roche Ltd., Fulgent Genetics, Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc. among others.
This carrier screening market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.
Download the Free Report Sample to Unlock the Carrier Screening Market Size for the Forecast Period and Other Important Statistics
The rising prevalence of genetic diseases and disorders is notably driving the carrier screening market growth, although factors such as varying regulations on carrier screening and research globally may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the carrier screening industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Carrier Screening Market Driver
One of the key factors driving the global carrier screening market growth is the rising prevalence of genetic diseases and disorders such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia. The increasing incidence of disabilities in newborns has surged the adoption of prenatal testing to quickly treat manageable genetic disorders and diseases. For instance, according to the CDC, 1 in every 33 babies (about 3%) is born with birth defects in the US every year. Similarly, between 7 million and 9 million babies are born with birth defects across the globe. In addition, parents with inheritable genetic conditions such as autosomal dominant and recessive disorders prefer early disease diagnosis through prenatal testing procedures. For instance, either parent having a gene with the autosomal dominant condition has a 50% chance of inheriting disorder to their offspring. Such factors are expected to positively impact the market growth during the forecast period.
Key Carrier Screening Market Trend
Rising trends of next-generation sequencing (NGS) technology in carrier screening is one of the key carrier screening market trends that is expected to support the market growth in the forecast period. NGS has elevated genetic research by enabling large-scale sequencing of the human genome to detect mutations and gene variants of intermediate to large size, which cause diseases/disorders. Sequencing innovations such as long-read sequencing have overcome sequence reading shortcomings of the widely used short-read sequencing technology, which only allows sequence reading up to 300 base pairs. The long-read sequencing technology has enabled end-users to perform sequencing reads between 10,000 and 900,000 base pairs. Vendors such as Illumina, Thermo Fisher Scientific, and QIAGEN have been key technology innovators for NGS instruments.
Key Carrier Screening Market Challenge
One of the key challenges to the global carrier screening market growth is varying regulations on carrier screening and research globally. Genetic test results used in in vitro diagnostics directly impact the decision-making capability of healthcare practitioners while treating critical health conditions. Thus, accuracy, safety, and the reliability of carrier screening procedures are of vital importance. This has resulted in the enforcement of stringent and complex regulations on carrier screening by various national and international regulatory authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), International Organization for Standardization (ISO), and others. The variations in standards among regulatory authorities hinder compliances, thereby threatening the swift business operation of vendors globally, which is expected to negatively impact the market growth during the forecast period.
This carrier screening market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the carrier screening market encompasses successful business strategies deployed by the key vendors. The carrier screening market is fragmented and the vendors are deploying growth strategies such as an increase in R&D investments to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The carrier screening market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
37% of the market's growth will originate from North America during the forecast period. The US is the key market for carrier screening in North America. Market growth in this region will be faster than the growth of the market in Europe.
Growing concerns on early disease diagnosis, a significant rise in commercial approvals for advanced carrier screening, and the increasing use of pharmacogenomic testing will facilitate the carrier screening market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the outbreak of COVID-19 adversely affected the carrier screening market in the region. The outbreak affected the growth of the carrier screening market as genetic counselors were unable to see patients personally due to the closure of laboratories. However, due to a decrease in the number of COVID-19 cases, lockdowns were lifted in 2021, which led to the resumption of import and export of raw materials in the region. This led to the recovery of the market to some extent in 2021. Therefore, the market is expected to grow during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The carrier screening market share growth by the expanded carrier screening segment will be significant during the forecast period. Advancements in the expanded carrier screening segment, such as Sema4 Elements Expanded Carrier Screen (ECS) with Personalized Residual Risk solution of Sema4 OpCo, Inc, will increase its demand, which, in turn, is expected to drive the growth of the segment during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the carrier screening market size and actionable market insights on post COVID-19 impact on each segment.
Technavio categorizes the global carrier screening market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the carrier screening market during the forecast period.
Our report provides extensive information on the value chain analysis for the carrier screening market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
High Throughput Screening - The market share is expected to increase by USD 11.10 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 7.83%.
Cellular Health Screening- The market share is expected to increase to USD 1.92 billion from 2021 to 2026, at a CAGR of 11.24%.
Carrier Screening Market Scope |
|
Report Coverage |
Details |
Page number |
123 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 17.66% |
Market growth 2022-2026 |
$ 2.36 billion |
Market structure |
Fragmented |
YoY growth (%) |
16.91 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Germany, UK, Japan, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, DiaSorin SpA, F. Hoffmann La Roche Ltd., Fulgent Genetics, Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Type
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.